Multikinase inhibitor AI-1008 shows promise to treat chronic myeloid leukemia in preclinical testing Dec. 1, 2010
CXR-1002 shows promising safety and antitumor activity in first-in-human trial in advanced cancer Nov. 30, 2010
Fresolimumab improves symptoms of primary focal segmental glomerulosclerosis in phase I trial Nov. 30, 2010
RSS